Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan Kozauer, MD
Intra-Cellular Therapies, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Site
Burgas, Bulgaria
- Clinical Site
Kardzhali, Bulgaria
- Clinical Site
Lovech, Bulgaria
- Clinical Site
Pleven, Bulgaria
- Clinical Site
Plovdiv, Bulgaria
- Clinical Site
Rousse, Bulgaria
- Clinical Site
Sofia, Bulgaria
- Clinical Site
Varna, Bulgaria
- Clinical Site
Veliko Tarnovo, Bulgaria
- Clinical Site
Vratsa, Bulgaria
- Clinical Site
Moscow, Russia
- Clinical Site
Nizhny Novgorod, Russia
- Clinical Site
Omsk, Russia
- Clinical Site
Saint Petersburg, Russia
- Clinical Site
Samara, Russia
- Clinical Site
Saratov, Russia
- Clinical Site
Tomsk, Russia
- Clinical Site
Belgrade, Serbia
- Clinical Site
Kovin, Serbia
- Clinical Site
Novi Sad, Serbia
- Clinical Site
Šumadija, Serbia
- Clinical Site
Ivano-Frankivsk, Ukraine
- Clinical Site
Kharkiv, Ukraine
- Clinical Site
Kropyvnytskyi, Ukraine
- Clinical Site
Odesa, Ukraine
- Clinical Site
Poltava, Ukraine
- Clinical Site
Smila, Ukraine
- Clinical Site
Vasylkiv, Ukraine
- Clinical Site
Vinnytsia, Ukraine
- Clinical Site
Rogers, Arkansas, United States
- Clinical Site
Cerritos, California, United States
- Clinical Site
Costa Mesa, California, United States
- Clinical Site
Culver City, California, United States
- Clinical Site
Garden Grove, California, United States
- Clinical Site
Glendale, California, United States
- Clinical Site
Lemon Grove, California, United States
- Clinical Site
Oceanside, California, United States
- Clinical Site
Pico Rivera, California, United States
- Clinical Site
Riverside, California, United States
- Clinical Site
San Diego, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2016
- Primary completion
- 2 Jul 2020
- Completion
- 2 Jul 2020
- Last update posted
- 17 May 2023
- Registered enrollment
- 529
- Registry id
- NCT02600507
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.